spacer
home > ebr > spring 2017 > managing e&l unknown compounds
PUBLICATIONS

 

Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time. Sign up now!

       Already registered? Please sign in.

Alternatively, please use our pay-per-view service.

spacer

Industry Events

3rd PDA Europe Annual Meeting

26-27 June 2018, Berlin Marriott Hotel

The ongoing theme of the European Annual Meeting is Global Healthcare of the Present & the Future, as it intends to continue spanning a bridge between current demands within the global healthcare industry, the amounting advanced technological and analytical opportunities and the promising prospects personalized medicine and medicinal products bring.
More info >>

 
News and Press Releases

RoslinCT to Participate in the Northern Alliance Advanced Therapies Treatment Centre

RoslinCT, a UK-based cell and gene therapy contract manufacturing organisation, is delighted to be part of the Northern Alliance Advanced Therapies Treatment Centre (NAATTC) consortium. As an industry partner within the consortium, RoslinCT will provide advice on the development, manufacture and clinical supply of cell, gene and tissue engineered therapies.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement